Header Logo

Connection

Mark Johnson to Phenylalanine

Back to Details
This is a "connection" page, showing publications Mark Johnson has written about Phenylalanine.
Mark Johnson
Connection Strength
0.033
Phenylalanine
  1. Low JA, Johnson MD, Bone EA, Dickson RB. The matrix metalloproteinase inhibitor batimastat (BB-94) retards human breast cancer solid tumor growth but not ascites formation in nude mice. Clin Cancer Res. 1996 Jul; 2(7):1207-14.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.